Causal association of nonalcoholic fatty liver disease with 22 extrahepatic cancers: A Mendelian randomization study
Hepatology Research · 2024-03 · 54 (3) · 261-271
DOI: 10.1111/hepr.13980 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hepatology Research, online erschienen am 14.11.2023. Verfasst von Jiarong Xie und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The First Affiliated Hospital of Ningbo University, Ningbo, China. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, The Medical Health Science and Technology Project of Zhejiang Provincial Health Commission.
Abstract (Originalsprache)
Aim
It is unclear whether nonalcoholic fatty liver disease (NAFLD) acts as a direct contributing factor to multiple extrahepatic cancers. We aimed to systematically investigate the causal relationships of NAFLD with extrahepatic cancers.
Methods
We conducted a two‐sample Mendelian randomization analysis to assess the causal effects of NAFLD on 22 extrahepatic cancers. We examined the association of NAFLD with extrahepatic cancers using multiple methods in the largest genome‐wide association study meta‐analysis to date. We also replicated the analyses and performed two independent sensitivity analysis in the largest genome‐wide association study of UK Biobank.
Results
Using the weighted median method, genetically predicted NAFLD was significantly associated with female breast cancer risk (odds ratio [OR] 15.99; 95% confidence interval [CI] 9.58–26.69). Genetically predicted NAFLD is associated with cervical and laryngeal cancers using the inverse variance weighting method, and the ORs were 2.44 (95% CI 1.43–4.14) and 1.94 (95% CI 1.35–2.78), respectively. We observed that patatin‐like phospholipase domain‐containing protein 3‐driven and transmembrane 6 superfamily member 2‐driven NAFLD were associated with increased risks of leukemia, lung cancer, and prostate cancers (all with p < 0.05). Furthermore, we confirmed the causal association between NAFLD and breast cancer using five known single‐nucleotide polymorphisms of NAFLD and six genome‐wide association study‐identified variants. The ORs of the weighted median estimator was 10.76 (95% CI 8.27–13.98) and 10.76 (95% CI 8.25–14.04), respectively ( p < 0.001).
Conclusion
Genetically predicted NAFLD is associated with an increased risk of female breast cancer, as well as cervical, laryngeal, leukemia, lung, and prostate cancers.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, The First Affiliated Hospital of Ningbo University, Ningbo, China.
- Department of Gastroenterology, Zhejiang Provincial Clinical Research Center for Digestive Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Department of Gastroenterology, Zhejiang Hospital of Integrated Traditional Chinese and Western Medicine, Hangzhou, China.
ORCID-Profile: Lei Xu
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- The Medical Health Science and Technology Project of Zhejiang Provincial Health Commission
- Natural Science Foundation of Ningbo
Zitieren
APA
Xie, J., Gao, H., Liu, C., Pan, Y., Xu, C., & Xu, L. (2024). Causal association of nonalcoholic fatty liver disease with 22 extrahepatic cancers: A Mendelian randomization study. Hepatology Research, 54(3), 261-271. https://doi.org/10.1111/hepr.13980
Vancouver
Xie J, Gao H, Liu C, Pan Y, Xu C, Xu L. Causal association of nonalcoholic fatty liver disease with 22 extrahepatic cancers: A Mendelian randomization study. Hepatology Research. 2024;54(3):261-271. doi:10.1111/hepr.13980
BibTeX
@article{Xie2024,
author = {Xie, Jiarong and Gao, Hui and Liu, Cenqin and Pan, Yue and Xu, Chengfu and Xu, Lei},
title = {Causal association of nonalcoholic fatty liver disease with 22 extrahepatic cancers: A Mendelian randomization study},
journal = {Hepatology Research},
year = {2024},
volume = {54},
number = {3},
pages = {261--271},
doi = {10.1111/hepr.13980}
}
EUVIMED